Tris Pharma, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in developing innovative drug delivery systems, particularly in the areas of paediatrics and chronic pain management. Tris Pharma focuses on creating unique formulations that enhance patient compliance and therapeutic outcomes, setting it apart from competitors. With a strong presence in the US market, Tris Pharma has achieved significant milestones, including the successful launch of several proprietary products that address unmet medical needs. The company’s commitment to research and development, coupled with its expertise in complex formulations, has solidified its position as a trusted partner in the pharmaceutical landscape.
How does Tris Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Tris Pharma, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tris Pharma, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Tris Pharma may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company does not inherit emissions data from any parent or related organisations, nor does it participate in recognised climate frameworks like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP).
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tris Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.